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INTRODUCTION 
The term diabetes was coined by Aretaeus of Cappadocia.it was 
derived from the greek word “diabainein”. Diabetes means one that 
straddles. Diabetes was  recorded first in English as Diabete around 
1425.  
In 1675, the word mellitus was added by Thomas willis. Matthew 
Dobson in 1776,confirmed the excess sugar in urine and blood.   
Sushrutha named diabetes as Madumeha(sweet urine disease) in 
6
th 
century. Avicenna Persian (980–1037) described diabetic gangrene.  
The role of pancreas in diabetes was first by Joseph von Mering 
and Minkowski.  1910 sir Edward albert Sharpey Shafer suggested that 
diabetic people were  deficient in insulin. 
 Banting and Best purified insulin from bovine pancreas for 
which he was awarded  noble price. Banting is honoured by worlds 
diabetes day  which is held on his  birthday, November, 14. 
 Amputations surgical principals was first given by Ambrose 
Pare. 
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AIMS AND OBJECTIVES 
The purpose of the present study is  
To analyze the level of CRP and adequacy of glycemic control in 
type 2 DM with diabetic foot on treatment. 
To correlate the level of CRP with sequelae of diabetic foot.  
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REVIEW OF LITERATURE 
Lin C W et al, after analysing 90 diabetic foot patients and 
concluded that reduced c reactive protein level (<50mg/l) indicates good 
prognosis in diabetic foot patients. 
1. Masayo Fukuhara et al,studied 195 residents and concluded 
good glycemic control in elderly  reduces systemic inflammation 
that contributes to  atherosclerosis in this study HbA1c was  used 
as glycemic index CRP used as marker for systemic 
inflammation. 
2. Baris A kinci, of DokuzEylul university hospital(2003-2008) 
observed 165 ulcer patients and  concluded that post treatment 
CRP values were strongly related to amputations. 
3. Dana.E.Kinget al, (NHANES III survey), 1988-1994 in his study 
concluded that CRP concentrations increased with raised HBA1c 
level and shows correlation between glycemic control and 
systemic inflammation in patients with proven diabetes. 
4. VOlaco Et al, Heinrich-Heine university, Germany studied 98 
diabetic foot patients with ischemic lesions and published that 
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high CRP levels are predictive of non healing ulcer and 
amputation. 
5. Anthonia.O.Oghera12, Langlos state university teaching 
hospital, Lagos state , studied 200 type 2 diabetes patients and 
published that elevated CRP and lipoprotein a was observed in 
diabetics than in non diabetics. 
6. Christian Weigelt et al, erman diabetic clinic (2003-2005) 
studied 125 patients with diabetic foot and his study revealed that 
diabetic foot ulcers and its complications are associated with 
elevated c reactive protein levels. 
7. Farah Jabeen Et al, studied 51 patients with type 2 diabetes and 
concluded  that elevated CRP levels and alteration in platelet 
morphology helps to identify diabetic patients who are at risk of 
developing complications. 
Pak J med sci, jan- mar 2012 vol.29, no. 1 
8. Mark.B.Pepys et al, a study in Royal free and university medical 
school UK (2003) revealed increased CRP level can predict 
peripheral vascular events in diabetic patients. 
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9. Wong Et al, (DIGAMI study (8), 1997 proved  a positive 
correlation between c reactive protein level and blood sugar level 
Editorial (Wong et al.., p 2971). 
10. Bejamin .A. Lipsky et al, evaluated 402 diabetic foot patients 
and concluded that severe wound grade ,elevated WBC count  
and increased CRP can predict unfavourable outcome in diabetic 
foot patients.  
11. KaushikBhowmick et al ,R.L.Jalappa hospital, Kolar ., 
Karnataka.( July 2005 –Dec 2005 ) studied patients with Type 2 
DM and concluded positive  correlation between CRP, 
microalbuminuria in Type 2 DM with poor glycemic control and 
normal CRP levels in adequately controlled patients.  
Indian Journal of  Biochemistry.2001/22(2) 53-59. 
12. Mohammed R. Ahmed, Zagazig university, Egypt published that 
in diabetic foot patients c reactive protein and MIF helps in 
differentiating infected from non infected diabetic foot. 
13. Debra. A.Schaumberg et al ‘s study ,diabetes control and 
complications trial demonstrated intense glycemic control in  
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diabetic patients reduces C reactive protein , TNF –R. Elevated 
CRP levels were associated with risk of  atherosclerosis. 
14. Lee Et al, study on diabetic foot patients showed that elevated 
CRP values are more useful in predicting infection when 
compared to WBC count and ESR. 
15. SabiullahAmanullah , Al Arab Medical university ,Benghazi , 
Libya, compared association of CRP in diabetic and non diabetic 
patients and that study revealed a strong correlation between CRP 
and glycemic control in diabetic individuals. 
Jordan Journal Of Biological Sciences, 
Volume 3, number 1, January 2010. 
16. Upchurch Et al, compared CRP level in diabetic foot ulcer 
patients and  diabetic patients without ulcer and concluded CRP 
level in foot ulcer patients. 
17. Pradhah Et al,2001;  Haffeiner(2003); Hanley Et al.(2004) 
studied CRP levels in diabetic patients  and concluded that CRP 
level elevated in diabetic patients and can be used as biomarker 
for inflammation. 
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18. Jeandrot Et al, study proved CRP has high sensitivity and 
speficity in predicting infection in diabetic foot patients. 
19. Rodriguez and Guerrero (1993) ,studied patients with type 2 
diabetes patients and concluded that decreased CRP levels were 
observed in patients with low HBA1c and a positive correlation 
between CRP and glycemic control. 
20. King DE et al, study proved elevated CRP level  correlates with 
raised HBA1c levels, showing association between glycemic 
control and systemic inflammation. 
Department of family medicine, medical university of south 
Carolina , Charleston 29425,USA. 
21. Li et al.2004and Aronson et.al 2004 study in diabetic patients 
showed positive correlation between CRP and HBA1c level and 
independent association of CRP with fasting plasma glucose. 
22. Scholin A et al studied 97 diabetic patients and concluded that 
elevated CRP levels has positive correlation with poor glycemic 
control. 
8 
 
Department of medical sciences,  Section of Internal Medicine,  
Uppsula university hospital, Sweden.  
23. Li cz et al (2004) study showed positive correlation between 
fasting blood sugar level with c reactive protein level. 
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DIABETES MELLITUS 
Diabetes and its complications is one of the most common cause 
of death. Prevalence of Diabetes worldwide is around  252 million. 
prevalance of diabetes in India is 42 million  and age of  distribution is 
middle and elderly people.  
There is 20% risk of developing diabetic ulcer in diabetic patients 
over a period of time.  
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DIABETES MELLITUS CLASSIFICATION: 
Type 1 IDDM (insulin dependent diabetes mellitus)   
Type 2 NIDDM 
Other types: genetic 
                       Infections 
                       Drugs/chemicals 
Endocrinopathies 
Gestational DM 
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DIABETIC FOOT 
Diabetic foot is the common complication in lower extremity. 13 
– 18% (percent)of patients will develop diabetic ulcer in foot over a 
period of time.  
Autonomic neuropathy, poor glycemic control, high pressure in 
soles are the  factors which contributes to development of ulcer and one 
of the  cause of non traumatic amputation of lower limb. 
In terms of level of amputation toe amputation is the most 
common. Rate of  amputation is 15 to 40 times high in diabetic patients 
when compared to normal. 
ULCER RISK: 
Single most common factor which determines amputation in 
lower limb is foot  ulceration. 
Risk factors which leads to foot ulceration involves 
polyneuropathy which includes  
          Autonomic 
          Sensory  
Motor neuropathy, 
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Trivial trauma  
Atherosclerosis of involved vessels. 
Approximately 50% of foot ulcerations are purely neuropathic, 
remaining have  neuropathic and vascular components. Out of which 
sensory neuropathy is the  leading factor which contributes to diabetic 
foot ulceration. 
Motor neuropathy leads to muscle wasting and foot deformities. 
Additionally  autonomic neuropathy Results in dry skin which cause 
fissures and crack causing  portal for entry of bacteria.  
Common deformities: 
Hallus valgus 
 Prominent metatarsal head 
Charcot joint 
Hammer toe deformity. 
Peripheral arterial disease also leads to foot ulceration.  
Mechanism being 
  Due to arterial insufficiency   
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prolonged healing time 
Lack of oxygen delivery to tissues. 
           Delivery of antibiotic to infected site is impaired. 
Due to longstanding diabetes glycosylation of collagen leading to 
thickening of  ligaments and capsule(CHIEROARTHROPATHY) 
which subsequently reduces  mobility of joint, high plantar pressure and 
development of ulceration. 
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                                                              Diabetes mellitus 
 
                            Polyneuropathy     Atherosclerosis  
         
Autonomic 
Dysfunction   sensory  motor            PVD 
 
medial              A-V shunts                                      muscle 
 calcification opening                                        atrophy 
 of vessels 
 
 
Hot turgid foot                                    insensible deformed               cold and pale  
Epidermal cutaneous ischemia                            foot                      foot 
 
    Extrinsic trauma                         pain insensibility and foot           gangrene 
 
        Ulceration     deformation 
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DIABETIC FOOT INFECTIONS: 
Diabetic foot infections are typically polymicrobial.  
Hyperglycemia 
Atherosclerosis 
Neuropathy 
Immunocompromised status are contributing factors which leads 
to foot infections  in diabetes. 
Due to impaired immune response and ischemia infection control 
in diabetes is  poor with antibiotics. Poor infection control leads to 
cellulitis cause irreversible  damage to tissues. 
16 
 
 
Diabetic ulcer classification system: 
Wagner classification system 
Grade  Lesion 
0      cellulitis or deformity,  no lesion 
           1                     Superficial diabetic ulcer 
           2                     Ulcer extension 
                                   Involves ligaments tendons joint capsule or fascia 
                                   No abcess or osteomyelitis 
           3                      Deep ulcer with osteomyelitis or abcess formation 
           4                      Gangrene to portion of fore foot 
           5                      Extensive gangrene of foot 
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University of texas classification: 
Stage                0                       1                          2                             3 
A  completely       superficial      Depth upto tendon     Involving bone  
 epithelialised      wound              or capsule               or joint 
 wound 
B         presence of         Infection           Infection  Infection 
 infection 
C         presence of           Ischemia          Ischemia  Ischemia 
             Ischemia 
D        presence of both   Infection and    Infection and         Infection and 
           Infection and               Ischemia          ischemia  ischemia 
Ischemia 
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AMPUTATION IN DIABETES: 
The incidence of amputation is 15 to 40 times greater in diabetes 
when compared to non- diabetes. 
And it serves as the marker for disease severity. Impairment of 
blood supply due to  atherosclerosis .May also be an independent factor 
causing amputation and predisposes to gangrene. 
Infection and chronic hyperglycemia has also been implicated as 
risk factor leading  to amputation. 
Infection leads to sepsis, soft tissue destruction, abcess formation 
and  osteomyelitis. 
Chronic hyperglycemia causes microangiopathy, glycosylation of 
collagen and  affects host phagocytosis mechanism. 
Both these factors will ultimately leads to amputation. Past 
history of amputation  and ulcer in the lower extremity are major 
determinant factors for subsequent amputation. 
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ASSESSMENT OF DIABETIC FOOT ULCER: 
Complete history and physical examination 
 Duration 
Glycemic status 
Existence of other comorbid conditions 
FOOT SPECIFIC 
 Foot deformity 
Callus formation 
 Previous infection 
Surgery. 
Laboratory screening:           
Fasting and post prandial blood sugar values 
           To calculate insulin dose 
           To assess glucose level 
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Complete blood count and RFT 
To look for changes due to diabetic nephropathy. 
HBA1c 
           To look for long term glycemic control 
Erythrocyte sedimentation rate 
C reactive protein 
           To look for severity of infections 
Alkaline phosphatase : 
will be elevated in diabetes 
Wound culture 
           To start the patient on appropriate antibiotics 
Serum lipid profile: 
It tells about vascular risk( atherosclerosis ) 
Urinalysis 
Ketones 
           To rule out ketoacidosis 
Dietary habits 
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IMAGING STUDIES: 
Plain radiograph : 
Detect bone changes like 
1.  osteolysis 
           2.  osteomyelitis 
           3.  fractures 
4. dislocations. 
Technetium-99 methylene diphosphonate: 
Predict presence of osteomyelitis. 
Increase uptake is seen in fracture, infections and neuropathy. 
Technetium-99 sulfur colloid: 
Actively functioning bone marrow  will show increased uptake, 
as  in osteomyelitis 
Differentiates osteomyelitis and neuropathic arthropathy. 
Indium 111 scans: 
Leucocytes are selectively labled in indium scan 
Specific for osteomyelitis. 
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CTscan: 
For joint and bony changes that are not seen in x rays. 
Subluxation can be visualized. 
Biopsy: 
           Correlates best with the duration of diabetes 
           Neuropathies will not occur in the initial period of onset of 
diabetes 
              The following nerve fibre changes are observed in 
histopathology 
              1.  myelination changes 
              2.  nervefibres density will be reduced 
              3.  degeneration of axons 
              4.  degeneration of pericyte in interstitium 
              5.  reduplication of basement membrane( neurilemma). 
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NEUROLOGICAL EVALUATION: 
Semmes Weinstein monofilament wire for assessing sensory 
function. 
             Patient not able to feel- loss of sensation present Biothesiometer 
for assessing vibration perception. 
>25volts significant neuropathy. 
Nerve conduction studies: In diagnosing peripheral neuropathy. 
 Pin prick              
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VASCULAR EVALUATION: 
Palpation of pulses 
NON palpable pulses : 
           Doppler segmental arterial pressure 
Toe blood pressure: 
Normal more than 60mm of Hg. 
Less than 40 critical limb ischemia. 
Doppler USG: Helps in planning further management 
Shows level of occlusion in macrovascular disease 
 Decide level of amputation. 
Laser Doppler velocimetry and measuring skin perfusion                                   
Pressure: assess flow in capillaries and superficial arterioles  
Predicts critical limb ischemia. 
Toe brachial index 
More than 0.7 – normal. 
Less than 0.64- arterial disease. 
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Arteriography: assess the level of arterial occlusion  
          To visualize collaterals 
Done by seldingers technique. 
         To visualize distal run off 
For revascularization procedures 
MR angiography and CT angiogram: evaluates distal arterial 
perfusion 
Ankle brachial index 
Interpretation of ABI 
Resting ABIseverity of obstruction 
0.91-1.30                          normal 
0.70-0.90                          mild 
0.40-0.69                          moderate 
<0.40                       severe 
 
 
26 
 
Indication for vascular intervention: 
ABI < 0.7 
Toe blood pressure< 40 mm of hg 
Transcutaneous oxygen tension < 30 mm of hg 
These factors are associated with poor healing. 
ASSESSING PLANTAR FOOT PRESSURE: 
THE HARRIS MAT( computerized): can identify areas vulnerable to 
ulceration 
           Measures plantar foot pressure 
PRESSURE STAT(non computerized): uses pressure sensitive sheets 
Used as screening tool to identify areas easily vulnerable to ulceration. 
Foot ulcer evaluation: 
Assess 
          Skin changes around the ulcer 
          Ulcer characteristics- size site shape 
         Condition of ulcer- wound edges and bed 
         Presence of necrosis, pain, cellulitis and gangrene 
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RISK CATEGORIZATION SYSTEM: 
Category                             Risk                                          Evaluation 
      0                                 Normal                                       every year 
      1                                Presence of peripheral               every 6 months  
                                        Neuropathy 
      2                                Presence of peripheral              every 4 months 
                                        Neuropathy,  PAD or  
                                        Deformity 
      3                                Amputations                               monthly to  
    Past h/o ulcer   quaterly 
PAINFUL NEUROPATHY MANAGEMENT: 
General measures: 
          1. Control blood sugar 
          2. Stop alcohol 
          3. Vitamin b12 supplementation 
          4. Educate the patient 
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Medical measures: 
          Tricyclic anti-depressants 
          Anti –Convulsants 
                    1. Sodium valproate. 
                    2. Phenytoin sodium. 
                    3. Carbamazepine. 
DRESSINGS IN DIABETES: 
Hydrocolloid dressing: 
Contains carboxy-methyl- cellulose and gelatin. 
Often combined with adhesives and elastomers. 
Wound debridement occurs by autolysis. 
Frequency of dressings can be reduced until 7 days. 
Disadvantages: 
Hypergranulation on long term use 
Hydrogel dressing: 
Hydrate wounds and debridement occurs by autolysis. 
Can be useful in painful and burning wounds. 
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Thick gels: PURILON 
INTRASITE 
Thin gels: SOLUGEL 
SULUSITE 
Can be kept in wound for 3 days. 
Alginate dressing: 
Synthesised from sea weed. 
Contains calcium ions – biodegradable. 
Needs active exudation from the wound for it to function. 
Contraindicated in dry wounds. 
Foam dressing: 
Used in exudative wound due to its absorbable property 
Provides thermal protection 
Cannot be used in the presence of infection 
Can be impregnated with silver and thus acts as bactericidal 
dressing 
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Iodine preparations: 
Antiseptic. 
Bactericidal action. 
Used in infected wounds. 
Usually combined with systemic antibiotics. 
Prevents skin excoriation in exudating ulcers. 
Especially used for cavitary wounds. 
TREATMENT OF DIABETIC FOOT: 
Wound bed preparation: 
       It has been proved that diabetic wound will not heal in the 
presence of debris, non viable tissues and bacterial colonisation. Wound 
debridement became integral  part in the management of diabetic foot. 
Debridement  
Removes all necrotic tissues and callus. 
Reduces pressure. 
Helps in evaluating wound bed. 
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Reduces bacterial burden. 
Facilitates drainage of abcess. 
Adequate debridement must be done before applying topical 
healing agents and wound closure. 
Various types of debridement: 
Surgical 
Enzymatic 
Autolytic 
Mechanical 
Biological  
Out of which only surgical debridement has been proven to be 
effective. 
Surgical debridement is done until healthy soft tissues active 
bleeding and bones are encountered. 
Main aim of debridement is to convert chronic non healing ulcer 
into acute healing ulcer.Any deep abcess associated with diabetic foot 
should be drained. If  osteomyelitis is encountered amputation should be 
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done. Necrotic tissues should be excised and debrided regularly. 
Frequent maintainence debridement is mostly required. 
Enzymatic debridement: 
Application of synthetic proteolyic enzymes for wound 
debridement. 
Eg.bacterial collagenase,  papain, trypsin, fibrinolysin. 
Autolytic debridement: 
Occurs in moist healthy environment.When blood supply is 
maintained. 
Mechanical debridement: 
This includes wet to dry dressing 
High pressure irrigation 
Pulsed lavage and hydrotherapy. 
Biological therapy: 
Here proteolytic enzymes secreted by maggots is used that 
liquefies necrotic.  
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Tissues to get nourishment for the development during their life 
cycle. 
Infection and inflammation control: 
Infection may be local involving  
soft tissue,  
systemic or 
ascending infection.  
As host immune system is compromised signs of inflammation 
will be absent. In such case elevated blood sugar value serves as marker 
for infection. Obtain culture and sensitivity report before starting 
antibiotics. 
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ADVANCED MODALITIES IN WOUND CARE: 
Growth factor therapy 
           Genetically engineered platelet derived growth factor 
Becaplermgel( REGRANE x tm) 
Works by stimulating chemotaxis. 
Autologous platelet rich plasma: 
Stimulates platelet alpha granules to release various growth 
factors. 
Bioengineered tissues: 
           Currently two products have been approved 
               1. Apligraft 
               2. Dermagraft 
Bilayered skin substitutes: 
Bilayered cultured composite skin. 
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Extracellular matrices: 
           From devitalized tissues 
Dermal regeneration template (integra tm) 
Allogenic dermal matrix (alloderm) 
Matrix of human dermal fibroblast. 
Adjunctive modalities: 
1. Regerative tissue matrix 
2. Hyperbaric oxygen therapy 
3. Ultrasonic therapy-MIST therapy  tm system 
Uses fine saline spray that allows USG administered directly to 
wound. 
4. negative pressure wound therapy 
Vacccum assisted closure device 
5. electrical stimulation. 
PRESSURE RELIEF /OFF- LOADING: 
        Totally non weight bearing- bed rest, crutches, foot casts or boot. 
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Rocker bottom sole with removable walking brace. 
Custom walking brace. 
        Wedge shoes/half shoes. 
        Tendon bearing braces- patella. 
       Assistive device- crutches cane walker. 
 Accommodative dressing. 
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MANAGEMENT OF CHARCOT FOOT: 
Diabetic neuropathy 
 
                                                 Ambulation                                                                                         
 
Laxity of ligaments  
                                                Joint instability  
Local inflammation                                               continued ambulation 
Subluxation of joints 
                                        Fragmentation of bones and joints 
 
Charcot foot deformity 
 
                                              Infection of ulcer 
 
                                               Amputation  
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Charcot arthropathy classification: 
Eichenholtz classification system: 
           Developmental active stage- active stage 
Coalescent – quiescent or reparative. 
           Reconstructive – quiescent or reparative stage. 
Management of acute neuroarthropathy: 
Main stay of treatment is Immobilization and stress reduction. 
Initial offloading: 
Non weight bearing- uses of crutches. 
Short leg plaster. 
Fibre glass non weight bearing cast. 
Pneumatic walking. 
Removable cast walker. 
Post acute phase of treatment: 
Following reduction in temperature and edema 
Protective weight bearing. 
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          Total contact cast: fixed ankle walker. 
Bivalve cast total contact prosthetic walker patellar tendon 
bearing braces. 
Moderately unstable ankles: ankle foot orthosis. 
high top therapeutic shoes. 
Severly unstable: patellar tendon bearing brace. 
Bisphosphonate therapy acts by inhibiting bone resorption 
Electrical bone growth stimulation. 
Low intensity pulsed ultrasound. 
Surgical management of osteoarthropathy: 
Indication of surgical intervention is subluxation without 
osteochondral fragments. 
Goal -to create stable plantigrade foot 
Includes- Exostectomies for rocker bottom deformity. 
Isolated or mid foot arthrodesis. 
Hind foot fusion. 
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Triple arthrodesis. 
Tibio calcaneal fusions. 
Ankle fusion. 
SURGICAL MANAGEMENT OF DIABETIC FOOT: 
Recent classification based on surgery 
Class 1 elective 
Class 2 prophylactic 
Class 3 curative 
Class 4 emergent 
Elective surgeries: 
Goal-to relieve pain associated with deformities 
All types of reconstructive surgeries fall in this category. 
Eg.ankle arthrodesis, Achilles tendon lengthening. 
Amputations only in severe deformity and joint instability. 
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Prophylactic surgery: 
Goal – to prevent occurrence and recurrence of ulceration 
Reconstructive procedures involving correcting tendon, bone and 
deformed joints fall in this category. 
Curative surgery: 
Goal –to promote healing of chronic non healing ulcer 
Removing peak pressure areas in the foot 
Removing infected bones and joints. 
Eg.exostectomy, sesamoidectomy, metatarsal head removal 
Joint resection partial calcanectomy. 
Emergent surgery: 
Goal –to stop progression of infection 
Eg.removing all non viable necrotic tissues to level of bone and 
viable soft tissue. 
Either primary closure of stump or delayed closure is done. 
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AMPUTATIONS CONSIDERTIONS: 
Distal stump should 
Easily accommodated by inert shot, prosthesis or orthotic device. 
Unlikely to break due to exogenous pressure. 
Should not cause dynamic or muscle imbalance. 
Should heal by primary intention. 
Amputation prevention programme: 
1. Foot care 
           Regular self examination 
           Risk assessment 
          Early treatment and detection of early lesions 
2. Protective shoes 
         Protects from injury 
         Well obstructed 
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3. Pressure reduction 
Padded hosters 
Cushioned multiple density moles 
Pressure measurements 
4. Prophylactic surgery 
          Correct surgical deformity 
          Prevent occurrence of ulcer 
5. Preventive education 
          Daily inspection 
         Patient education 
          Physical education- importance of foot examination 
Teaching recent concepts in diabetic foot management. 
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MANAGEMENT OF DIABETIC FOOT ACCORDING TO 
GRADE OF ULCER 
Grade I diabetic ulcer: 
ulcers which penetrate beyond  epidermis 
Indicates two risk factors involvement:  
Peripheral sensory neuropathy + other risk factor.  
Ulcer clinically evaluated. 
Primary surgical debridement of hyper keratotic area. 
Depth of  defect post debridement area assessed. 
           Surgical debridement is the best debridement method. 
Sharp debridement- 
With  scalpel all necrotic and dead tissues removed. 
           Until active bleed from the ulcer is seen. 
Surgical debrimentcarried out in OR under suitable anaesthetic 
agent. 
Pressure sites eliminated in foot by providing suitable 
offloading equipments.  
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Non-weight bearing crutches . 
Due to poor compliance following this regimen is difficult. 
Total contact casting. 
The felted foam dressing. 
            It is cost effective and compliance is good. 
                     Can be used as adjunct in the treatment of diabetic foot 
                      Before application measure the size of wound. 
Procedure: 
Aperture is created in the dressing, specifically the felted foam. 
Trim the edges with scissor.  
Trim along the opening close to the wound. 
This is to prevent “EDGE EFFECT”. 
           Paint the foot with rubber cement, on both side of each felted 
foam.  
Allow it to dry. 
Felted foams are laminated. 
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With foam in the bottom and felt in the top. 
Secure dressing with self-adherent around the foot  
Create  window  
Which allows dressing  
Direct visualization 
Assess the lesion 
           Provide healing shoe so that the patient can wear while 
ambulating.  
Pads  kept in place for 2 weeks  
Reapply  if necessary. 
Pros:  
           Frequent dressing can be done 
           Wound can be inspected daily.  
Cons: 
Foot has to be kept dry 
Frequent ambulation not possible. 
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The ulcer is addressed daily to create favourable environment. 
Systemic antibiotics to control infections according to culture 
reports. 
 Correct foot deformity surgically. 
Grade II diabetic ulcer: 
When patients with grade 1 lesions continue to bear weight 
ulceration becomes deep to involve other structures. 
X ray foot has to be taken to rule out any bony changes. 
Grade II lesions should not contain any bone changes. 
Examine : for presence of  sinus tract for deep structure involvement. 
Diagnose osteomyelitis: 
By Technetium 99 biphosphonate 
Technetium 99 sulphur colloid 
CT scan 
           Bone biopy 
Management includes: 
Strict bed rest 
Broad-spectrum antibiotics. 
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           Drain the foot in  dependent area and pack. 
This should be done in OT. 
Explore and drain the sinus tract if present. 
Surgical debridement of all dead tissue . 
This is done thoroughly and aggressively. 
Take culture from deep tissues. 
Start IV antibiotics according to culture report. 
Look for vascular changes by investigation. 
Consult vascular surgeon after initial debridement. 
Delay in surgery cause  
           Tissue loss  
           Potential limb loss 
         Twice daily  Dressing should be done. 
Frequent debridements before closure of wound. 
Once granulation tissue is formed definitive treatment is done. 
Or leave the wound to contract and heal by secondary intention. 
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Grade II diabetic ulcer takes long time to heal as the wound is 
deep And weight bearing might be difficult due to unhealthy scar. 
If possible the wound should be closed primarily. 
Treatment principles are same as of grade I ulcer 
           Non-weight bearing  
           Weekly debridement 
Frequent Dressings. 
Oral antibiotics. 
Grade III diabetic Foot: 
Grade III wound involves bone or abcess formation 
Predisposing factors: 
           Grade II ulcers not responding to treatment 
           Uncontrolled bacterial infections 
           Puncture wounds involving bone. 
Will require admission and surgical intervention . 
Abcess drainage  is  essential . 
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           Explore sinus tract if present drain the abcess and debride 
necrotic tissue. 
           Ray amputations may be needed in some patients  control 
infection.  
Clear the infection  
Wait for the  granulation to appear 
Wound reconstruction . 
Reconstructive surgical options: 
           Resection of bone, 
           Using flaps to reconstruct the defect, 
Grafting of skin. 
 Due to bone involvement the patient often uses opposite limb and 
pressure will be transferred to adjacent foot. 
Prevention: 
Orthoses 
Use of appropriate footwear  
Podiatric visit frequently. 
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Change the orthoses if  there are signs of breakdown. 
Long term  treatment goal  is even  distribution of plantar foot 
pressures over the entire foot, thereby avoiding any focal pressure. 
Grade IV diabetic foot: 
          Risk factors which makes the management difficult includes 
                    Presence of PVD, 
                    Bone involvement osteomyelitis,  
                    Presence of sepsis  
                    Excess necrotic tissue 
           Management requires multidisciplinary team.  
Management: 
Goal is primarily to limit the tissue loss. 
          Arterial insufficiency if severe results in gangrene. 
As end arteries are involved distal end of lowerlimb is often affected. 
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Inadequate perfusion 
 
Poor oxygenation 
 
Focal area necrosis 
 
Dry gangrene. 
 
Infection 
 
Gangrene changes 
 
Edema of local tissue 
 
Infective vasculitis 
wet gangrene. 
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Vascular insuffiency should be addressed immediately. 
If possible revascularisation procedures should be done to 
minimize  tissue loss. 
Grade V diabetic foot: 
Direct cause : 
Arterial occlusion and failure of arterial inflow. 
          Amputation is the primary treatment for gangrene 
          Similar to grade IV lesions assess vascularity and if possible 
revascularisation should be done  
To increase the perfusion 
           To prevent tissue loss and  
           Allow for distal level amputation. 
54 
 
CRP AND DIABETIC FOOT 
C REACTIVE PROTEIN: 
Before 1990,  the value of c reactive protein assays in the  
diagnosis and prognosis was not clearly defined. 
Later, it was found that CRP can strongly predict cardio vascular 
events in a value range which was previously considered normal CRP 
can never be used to diagnose disease, but their values can be used to 
interpret  and it can contribute to active management of disease , just lie 
patient  body temperature 
SYNTHESIS: 
CRP is synthesized by hepatocytes and its level rises to 1000 fold 
during inflammation CRP belongs to acute phase reactants. Spectrum of 
proteins the level of which may fall in response to  
 Infection 
 Inflammation  
 Tissue damage 
 Malignancy. 
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Cytokines stimulate production of CRP. This includes 
 Interleukin 1 
 Interleukin 6 
 Tumour necrosis factor. 
The main function of cytokine is that it acts as signal molecules 
which are produced by body’s immune system. 
Similar acute phase reactants produced  by liver 
 Protease inhibitors 
 Members of complement system 
 Carrier proteins  
 Serum amyloid protein  A(SAA) 
The sensitivity and specificity of CRP correlates best with SAA. 
Structure of CRP: 
Belongs to pentraxin family arranged in cyclical manner. 
Has promoters- five similar non glycosylated polypeptide non 
covantely bound subunits. 
Contains two calcium ligands. 
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For CRP to bind to phosphocholine( found in the cell membrane) 
calcium is needed. 
Due to presence of calcium in serum it helps in the binding of 
CRP with  phosphocholine. 
This clearly defines that serum calcium is the main factor which 
determines CRP level and CRP binding capacity with phosphocholine. 
Main functions of CRP: 
 Intracellular signaling. 
 In turn carries Cellular reactions. 
The level of serum calcium is usually low and increased level of serum 
calcium levels is observed in  
Cell damage 
Apoptosis  
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CRP 
 
Binds to phosphocholine 
In damaged and dead cells 
 
Increased lyso-phospholipid 
 
Lyses plasma membrane 
 
Binding of CRP with dead cells 
Physiological properties of CRP: 
CRP activates complement system  
classic complement pathway 
Normally phosphocholine is exposed in bacterial cell wall but not 
in human cell. 
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When damaged by complement system, phosphocholine becomes 
exposed  CRP binds to damaged cell membrane. 
 
 
C reactive protein 
 
Apoptotic 
Bacteria  
Cell membrane                                                     
 
 
Phosphocholine                                                            Activate classical  
                                                                                                        
       Complement pathway 
 
Binds to FCgRII 
And FCgRI 
On leucocytes membrane 
 
Increase phagocytosis 
 
Release of inflammatory cytokines 
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         CRP 
 
       Release of       cytokines                             damaged    cellwall 
 
                                          Stimulates  
phagocytosis 
 
Serum concentrations: 
Following single stimuli around 5mg/dl of CRP will be produced. 
Peak value – 48 hours 
Half life – 19 hours 
Mild inflammation < 40 mg / dl 
Severe bacterial infections 40 – 200mg /dl 
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No diurnal variation  
Hepato cellular failure results in decreased production of CRP  
By measuring CRP  
Screen for organic disease 
Monitor treatment response in inflammation and infection. 
CRP and atherosclerosis: 
Crp can in directly measure atherosclerosis. 
Any chronic inflammation is pro-atherogenic, even if non 
vascular. 
There is a positive correlation between CRP and atheromatous 
events. 
Elevated CRP levels are associated with metabolic syndrome and 
diabetes mellitus. 
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CRP 
 
  Stimulate tissue                                                  Selectively 
    factor             binds to LDL 
 
procoagulant effects  Especially oxidized and degraded LDL 
found in atheromatous plaques. 
 
Activates complement 
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MATERIALS AND METHODS 
Setting : Department of General Surgery, Government 
Stanley Hospital, Chennai 
Study design : PROSPECTIVE OBSERVATIONAL STUDY 
Study period : 1 years 
Materials : Approx. 100 patients 
Inclusion 
Criteria 
: All  type 2 DM patients on treatment and                          
diabetic foot. 
Exclusion 
criteria 
: patients with clinical or biochemical evidence         
of sepsis other than diabetic foot. 
Patients with active auto immune disease(RA, 
SLE,systemic sclerosis) 
   
All patients admitted in SMC-GS ward with diabetes and diabetic 
foot during JAN 2012 – NOV 2012 are included in this study. Thorough 
history and clinical examination  done. 
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Admission sugar values, CRP  values are obtained. Blood sugar 
and CRP estimation done by standard method. Grading of diabetic foot 
is done as per wagner classification. 
As per the standard protocol all patients treated with medical and 
surgical care as available in institution. Throughout the admission serial 
measurements of blood sugar are done and documented. Weekly CRP 
values are obtained till discharge. 
Using statistical analysis sugar values and CRP values are  
correlated with the grade of diabetic foot and treatment outcome. 
The study is done after the patients sign the informed consent 
form. 
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OBSERVATION AND RESULTS 
From January 2012 – November2012 , a total of  100 patients 
who was admitted with diabetic foot  in the Department Of General 
Surgery ,Government Stanley Hospital  was studied. 
After admission routine blood investigations radiological 
evaluation. Wound swab culture and sensivity were done.  
Blood sugar values both fasting and post prandial and c reactive 
protein levels were checked in all patients. 
Both oral and intravenous antibiotics were prescribed according 
to the pus culture and sensitivity report. 
Initial through surgical debridement was done 
Daily dressings were done. 
The fasting blood sugar value ranges from 127 to 225 .minimum 
value is presentation 127 and the maximum value 225.patients are 
categorized into five groups  to find the distribution  and they are shown 
in the table below. 
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FASTING BLOOD 
SUGAR 
NO OF PERSONS PERCENTAGE 
126-146 21 21% 
147-166 27 27% 
167-186 22 22% 
187-206 17 17% 
>206 13 13% 
 
DISTRIBUTION OF PATEINTS IN RELATION TO FASTING 
SUGAR. 
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POST PRANDIAL 
BLOOD SUGAR 
NO OF PERSONS PERCENTAGE 
200-240 18 18% 
241-280 31 31% 
281-320 23 23% 
321-360 15 15% 
>360 13 23% 
 
Similarly patients are classified into five groups based on the post 
prandial blood sugar values. Lowest value 203 and highest sugar level 
394. The distributions are shown in the table above.  
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Based on wagnersgrading  which describes the depth of wound 
patients are Categorized. And the table below shows the distribution of  
patients according to the severity of wound at presentation. 
WAGNER’S 
GRADING 
NO OF PATIENTS PERCENTAGE 
GRADE 1 48 48% 
GRADE 2 27 27% 
GRADE 3 16 16% 
GRADE 4 3 3% 
GRADE 5 6 6% 
 
DISTRIBUTION OF PATIENTS ACCORDING TO WAGNERS 
GRADING 
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Outcome Number 
Amputated 9 
Healed 91 
 
This chart implies the outcome in diabetic foot patients. Out of 
100 patients 9 got amputated and in 91 patients wound healed without 
complications.  
OUTCOME 
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CRP VALUE NO OF PATIENTS 
< 40 73 
>40 27 
 
This chart depicts the number of patients whose CRP value was 
greater than  and less than 40. Out of 100 patients 73 patients have got 
CRP value greater than 40 and 27 patients have got CRP value less than 
40. 
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CRP ABOVE 40 OUTCOME PERCENTAGE 
27 9 33.33 
27 18 67.66 
 
 
This table implies the outcome in patients whose crp values are 
above 40 out of 27 patients whose CRP values greater than 40 9 patients 
got amputated and 18 patients wound granulated and healed after 
adequate wound debridement and slough excision.  
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DISCUSSION 
After  analyzing the results of our study conducted from January 
2012 to November 2012 we observed significant level of correlation 
between glycemic control CRP level and outcome in terms of wound 
healing and amputation. 
After analyzing CRP levels in all patients it is observed that in 
patients with CRP level greater than 40 were 27. Out of which 9 got 
amputated and in the remaining patients the wound healed after surgical 
treatment. 
In our patients out of 100 patients who were evaluated in our 
study the least fasting value was 127 highest fasting value was 225 
similarly patient with least post prandial level is 208 patient with highest 
post prandial level is 394. 
It is observed that persistently elevated fasting and post prandial 
also had elevated CRP level in the blood, which in term is poor 
prognosis in terms of outcome. 
All the hundred patients were grouped into 5 subsets  on 
increasing level of fasting blood sugar. In which highest number 27 
persons(27%) falls in 2
nd
 subset(blood sugar values between 147-166). 
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22 patients falls in 3
rd
 subset(blood sugar between 167-186).21 patients 
falls in 1 st subset (blood sugar between 126-146).17 patients falls in 
4rth subset (187-206).and 13 patients falls under 5
th
 subset 
(values >207). 
Similarly the same patients were divided into 5 subsets based on 
rising post- prandial level. Out of which 31 patients(31%) falls in 2
nd
 
subset( blood sugar value between 241-280).23 patients falls under 3 rd 
subset (blood Sugar value between 281-320).18 patients falls in 1 st 
subset blood sugar value between 200-240. 15 patients falls under 4rth 
subset blood sugar value between 321-360.13 patients falls in 5
th
 subset 
blood sugar value greater than 360. 
Based on several studies and results so far conducted , it has been 
clearly stated the glycemic control in terms of fasting and post- prandial 
plays a pivotal role in the outcome of diabetic foot patients.patients who 
had persistently elevated fasting and post prandial levels has gone for 
amputation, our study too concludes the same 
That the patients who had persistently high fasting and post 
prandial level went in for amputation. 
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So we concluded  that, by and far the most important factor 
influencing the outcome in diabetic foot patients is the glycemic control 
in terms of outcome amputation and wound healing.  
In patients with elevated fasting and post prandial blood sugar in 
consistently elevated manner the response to treatment was poor with 
antibiotics and there was no improvement in wagner’s grading since the 
wound healing was low, the time taken for granulation tissue to appear 
was prolonged, when compared to patients with good glycemic control.  
In certain patients the CRP level was also elevated to critical level 
of 40 according to our study and apparently was treated by amputation. 
So, it is highlighted and emphasized that there is a strong 
correlation between glycemic control and outcome in terms of 
amputation and wound healing in patients with diabetic foot. 
Good glycemic control significantly reduces the morbidity in 
patients with diabetic foot. 
After analyzing the results drawn from 100 patients it has been 
clearly stated that CRP level assumes significance in relation to outcome 
in patients with diabetic foot. 
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Usually the CRP level is not detectable in the blood.values<5 mg 
is normal.whereas in diabetes whose glycemic status is poor CRP is 
found to be significantly elevated, invariably in all those patients with 
diabetic foot. 
After analyzing the results drawn by  Lin C W et al , Baris A 
kinci, Sabiullah Amanullah, it was concluded  that values < 45 -50   
mg indicates good prognosis in diabetic footin terms of outcome which 
may be amputation or healing. 
In our study out of 100 patients 27 patients  has elevated CRP 
levels > 40 mg .out of these 27 patients 9 patients were amputated either 
by above and below knee amputation and remaining patients healing of 
wound was observed. 
It is interesting to note that patients who had elevated CRP > 40 
also had extensive with gross level of infection when compared to rest 
of patients.this was assessed using wagner’s grading. Which grade the 
patients into 5 subgroups based on depth of tissue involvement. 
Out of 9 patients who went in for amputation 3 patients falls 
under wagners grade 4 and 6 patients wagners grade 5. 
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By several studies and research conducted so far, in the medical 
literature it has been concluded that the patients in higher end of grading 
has ultimately gone for amputation which was similar to that of results 
drawn in our study. 
Out of 27% of patients with elevated CRP level >40, 9% of total 
patients went in for amputation and in 18 patients wound healed. so the 
chance of having the risk of amputation when the CRP level is greater 
than 40 is 33.33%. 
It is also observed from our study that the patients have got 
elevated CRP but not went in for amputation have sustained slower rate 
of wound healing, whereas in those patients who have got CRP < 40 had 
good response to treatment with quick recovery and wound healing. 
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CONCLUSION 
From our study it is concluded that glycemic control and CRP has 
definitive correlation with outcome which is proved by patients with 
persistently elevated blood sugar levels and CRP went in for amputation 
in our study. 
It is also concluded that 33.33% ( 9 patients out of 27) patients 
with elevated CRP above the critical value of 40 have went in for 
amputation. Rest of the patients with CRP < 40 went in for wound 
healing with appropriate surgical management.  
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NAME AGE SEX IP NO FASTING
Manogar 52 m 44200 145
135
127
Mogli 55 m 14782 147
139
98
jayakumar 67 m 11335 170
148
78
Rajeshwari 38 f 30544 174
135
107
Kamatchi 40 f 10108 181
137
87
Jayachandran 55 m 42613 186
106
Sagayamary 45 f 44278 187
148
116
Krishnamma 65 f 50682 194
167
123
Muthu 36 m 32060 194
156
102
Sudhamani 70 f 46187 195
163
Sarroja 70 f 50765 197
178
124
Puspha 65 f 17276 199
168
132
Lucas 80 m 27954 201
156
112
Mani 65 m 44672 202
157
123
Muthuraj 40 m 44194 208
154
128
Rammaya 70 m 52100 209
231
220
Dharanidharan 35 m 6988 211
186
147
meenakshi 53 f 23312 213
234
228
Krishnaveni 60 f 51941 217
167
154
145
subramani 50 m 51049 218
187
167
148
Selvaraj 63 m 26309 219
182
164
Udhayakumar 45 m 42537 219
198
183
Jothi 58 f 42336 224
212
157
Chandrasekar 30 m 27854 225
203
156
durai 72 m 74521 185
163
144
Baskar 48 m 4359 137
124
Munusamy 55 m 41567 183
146
98
POST 
PRANDIAL
C REACTIVE 
PROTEIN
GRADE
243 45.6 grade 2
245
220 36.5
244 45.6 grade 2
219
175 23.9
289 48.1 grade 2
203
167 40.2
296 41.2 grade 2
242
195 29.7
307 45.1 grade 2
256
157 38.2
315 42.9 grade 2
211
316 45.9 grade 3
239
175 40.1
330 67.2 grade 3
290
198 42.3
332 57.2 grade 3
279
203 41.2
335 40.3 grade 3
254
342 48.3 grade 3
256
214 26.9
345 52.4 grade 3
283
180 34.9
349 73.2 grade 2
245
187 37.6
353 96.3 grade 3
254
187 45.4
361 78.2 grade 4
271
207 59.8
364 69.2 grade 4
321
354 70.3
367 76.3 grade 5
304
264 49.3
371 87.9 grade 5
267
287 76.3
377 65.2 grade 5
339
285 63.6
238 56.2
380 59.4 grade 5
287
246 55.3
313 62.3
382 42.2 grade 3
311
275 43.2
386 123.4 grade 5
312
274 87.3
316 85.7 grade 5
184
156 54.3
394 67.8 grade 4
345
254 69.3
312 53.9 grade 3
287
243 41.7
232 57.4 grade 1
176
308 61.3 grade 3
267
205 47.3
OUTCOME
healed
healed
healed
healed
healed
healed
healed
healed
healed
healed
healed
healed
healed
healed
amputation
amputation
amputation
amputation
amputation
amputation
healed
amputation
amputation
amputation
healed
healed
healed

 
